Showing results (11-20 of 142) with videos related to
Sort By:
Pageof 15
Current Opinion in Molecular Therapeutics|March 12, 2004
Hematopoietic stem cell transplant as a platform for tumor immunotherapyEphraim J Fuchs, Katharine A WhartenbySeminars in Hematology|October 30, 2016
Selecting the best haploidentical donorShannon R McCurdy, Ephraim J FuchsAdvances in Hematology|December 30, 2015
Comparable Outcomes for Hematologic Malignancies after HLA-Haploidentical Transplantation with Posttransplantation Cyclophosphamide and HLA-Matched TransplantationShannon R McCurdy, Ephraim J FuchsCurrent Opinion in Oncology|February 26, 2003
Nonmyeloablative alternative donor transplantsLeo Luznik, Paul V O'Donnell, Ephraim J FuchsSeminars in Oncology|December 5, 2012
Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantationLeo Luznik, Paul V O'Donnell, Ephraim J FuchsNature Reviews. Clinical Oncology|August 26, 2015
Modern approaches to HLA-haploidentical blood or marrow transplantationChristopher G Kanakry, Ephraim J Fuchs, Leo LuznikCurrent Opinion in Hematology|September 10, 2010
High-dose cyclophosphamide for graft-versus-host disease preventionLeo Luznik, Richard J Jones, Ephraim J FuchsBiology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2009
HLA-haploidentical stem cell transplantation for hematologic malignanciesEphraim J Fuchs, Xiao-jun Huang, Jeffrey S MillerBest Practice & Research. Clinical Haematology|September 20, 2011
Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamideAshley T Munchel, Yvette L Kasamon, Ephraim J FuchsUrology|September 18, 2009
Cryoimmunotherapy in urologic oncologyAbhinav Sidana, Wasim H Chowdhury, Ephraim J Fuchs, et al.Pageof 15